These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29080340)

  • 21. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid.
    de Haan LR; Verheij J; van Golen RF; Horneffer-van der Sluis V; Lewis MR; Beuers UHW; van Gulik TM; Olde Damink SWM; Schaap FG; Heger M; Olthof PB
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33578971
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
    Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
    Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
    Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.
    Yang S; Wei L; Xia R; Liu L; Chen Y; Zhang W; Li Q; Feng K; Yu M; Zhang W; Qu J; Xu S; Mao J; Fan G; Ma C
    Biochem Biophys Res Commun; 2019 May; 512(4):770-778. PubMed ID: 30928103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
    Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
    Zollner G; Trauner M
    Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targets for cholestatic liver injury.
    Woolbright BL; Jaeschke H
    Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholemic nephropathy - Historical notes and novel perspectives.
    Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases.
    Yang T; Khan GJ; Wu Z; Wang X; Zhang L; Jiang Z
    Drug Discov Today; 2019 Jan; 24(1):112-128. PubMed ID: 30244079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy.
    Panzitt K; Fickert P; Wagner M
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166017. PubMed ID: 33242590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
    Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
    Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.
    Li T; Apte U
    Adv Pharmacol; 2015; 74():263-302. PubMed ID: 26233910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
    Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New therapeutic concepts in bile acid transport and signaling for management of cholestasis.
    Trauner M; Fuchs CD; Halilbasic E; Paumgartner G
    Hepatology; 2017 Apr; 65(4):1393-1404. PubMed ID: 27997980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.
    Yang QL; Yang F; Gong JT; Tang XW; Wang GY; Wang ZT; Yang L
    Acta Pharmacol Sin; 2016 Sep; 37(9):1218-28. PubMed ID: 27498779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation: Cause or consequence of chronic cholestatic liver injury.
    Woolbright BL
    Food Chem Toxicol; 2020 Mar; 137():111133. PubMed ID: 31972189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of inhaled carbon monoxide in endotoxin-induced cholestasis is dependent on its kinetics.
    Vanova K; Suk J; Petr T; Cerny D; Slanar O; Vreman HJ; Wong RJ; Zima T; Vitek L; Muchova L
    Biochimie; 2014 Feb; 97():173-80. PubMed ID: 24148277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.